Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Benefit with post-consolidation blinatumomab in newly diagnosed high-risk B-ALL. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1056/nejmoa2604166
10.1056/nejmoa2604166 · 2026 · External reference